Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
The Heart Team during the Pandemic: A Case Report of Bio-Prosthesis Degeneration Treated with Valve in Valve Implantation
Beteiligte:
Manes, Maria Teresa;
Ritacco, Anna Rita;
Cassano, Susanna;
Ferrò, Maria Teresa;
Manduca, Bruno;
Spaccarotella, Carmen;
Musacchio, Domenico
Erschienen:
Medknow, 2024
Erschienen in:
Journal of Cardiovascular Echography, 34 (2024) 2, Seite 77-81
Sprache:
Englisch
DOI:
10.4103/jcecho.jcecho_12_23
ISSN:
2211-4122;
2347-193X
Entstehung:
Anmerkungen:
Beschreibung:
The pandemic changed the type of patients. The concept of “patient at the center” became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The “Heart Team” model is on increasing affirmation. The TEAM-BASED approach in the cardiology field is successfully used in patients suffering from ischemic heart disease and valvulopathies for the choice of possible treatments. Degenerative type Sao is the most frequent valvulopathy among the valvulopathies in Western countries and its incidence is correlated with age. In high-risk patients, percutaneous valve replacement (transcatheter aortic valve implantation) is the most valid therapeutic option. The implantation of biological prostheses raises the problem of both degeneration and dysfunction of the prosthesis itself over time in subjects of advanced age and with comorbidities. In this scenario, valve-in-valve (VinV) is a valid therapeutic alternative in high-risk patients. A clinical case of aortic prosthetic degeneration, as an outcome of endocarditis, treated with VinV is presented. The therapeutic decision was made by an “Electronic Heart Team” which represents a further evolution of the treatment pathways and reduces the distance between the specialists in “Hub” Centers and the “Spoke” center. Summary The advent of the pandemic caused active collaboration and fruitful discussions among medical specialists. As a matter of fact, a shift from a simple consultation to the establishment of a proper “Heart Team” model occurred and the concept of “patient at the center” arose. TEAM-BASED approaches in cardiology are being successfully used as possible treatments in patients suffering from ischemic heart disease and valvulopathies. Degenerative type Sao is the most frequent valvulopathy in Western countries and its incidence is correlated with age. In high-risk patients, percutaneous valve replacement (TAVI) is the most viable treatment option. However, in subjects of advanced age, with comorbidities, the implantation of biological prostheses is associated with the degeneration and dysfunction of the prosthesis itself over time. In this scenario, Valve-in-valve (VinV) is a viable therapeutic alternative in high-risk patients. A clinical case of aortic prosthetic degeneration, as an outcome of endocarditis, that was treated with VinV is presented. The decision on VinV was made by an “Electronic Heart Team” which represents a further evolution of care pathways to reduce the distance between the “Hub” Centers and the specialist at the “Spoke” center.